Literature DB >> 7905815

Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences.

M Drent1, S S Wagenaar, P H Mulder, H van Velzen-Blad, M Diamant, J M van den Bosch.   

Abstract

The aim of this study was to identify characteristic features in bronchoalveolar lavage fluid (BALF) samples of patients with tuberculosis, non-Hodgkin's or Hodgkin's disease and to investigate whether these differences facilitate the distinction of those disorders from sarcoidosis presenting with a similar clinical picture. Nonsmoker patients with histologically verified sarcoidosis (n = 29), tuberculosis (n = 6) proven by positive culture, non-Hodgkin's disease, (n = 6) or Hodgkin's disease (n = 7), both histologically verified, were investigated by BAL. A control group consisted of subjects without any pulmonary history. The presence of CD4+ and CD8+ T lymphocytes, as well as the CD4/CD8 ratio in BALF, aided in the differentiation between the various groups. Patients with malignant lymphomas had the lowest CD4/CD8 ratio in BALF, as well as in peripheral blood, and occasionally, plasma cells were present in BALF samples. The most important feature of BALF analysis in tuberculosis was detection of the causal microbial agent. In conclusion, although malignant lymphomas and tuberculosis require histologic evaluation and a positive culture, respectively, for diagnosis, BALF analysis may be of additional value in distinguishing those disorders from sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905815     DOI: 10.1378/chest.105.2.514

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Spontaneous interleukin 2 release of bronchoalveolar lavage cells in sarcoidosis is a codeterminator of prognosis.

Authors:  J Müller-Quernheim; S Pfeifer; K Kienast; G Zissel
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Lung cancer in patients with tuberculosis.

Authors:  Saulius Cicenas; Vladislavas Vencevicius
Journal:  World J Surg Oncol       Date:  2007-02-19       Impact factor: 2.754

Review 4.  The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article.

Authors:  Yongmei Yin; Jie Qin; Yaping Dai; Fanwei Zeng; Hao Pei; Jun Wang
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

5.  Primary pulmonary lymphoma mimicking a refractory lung abscess: A case report.

Authors:  Takeshi Matsumoto; Kojiro Otsuka; Yuki Funayama; Yukihiro Imai; Keisuke Tomii
Journal:  Oncol Lett       Date:  2015-02-03       Impact factor: 2.967

6.  The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings.

Authors:  Robert Kieszko; Paweł Krawczyk; Tomasz Powrózek; Aneta Szudy-Szczyrek; Michał Szczyrek; Iwona Homa; Jadwiga Daniluk; Janusz Milanowski
Journal:  Arch Med Sci       Date:  2015-04-28       Impact factor: 3.318

7.  Primary pulmonary mucosa-associated lymphoid tissue lymphoma: A case report.

Authors:  Mohammad Reza Hosseini Siyanaki; Elham Askari; Sara Haseli; Nazanin Sadraei
Journal:  Radiol Case Rep       Date:  2022-10-08

8.  Combined detection of lymphocyte clonality and MALT1 translocations in bronchoalveolar lavage fluid for diagnosing pulmonary lymphomas.

Authors:  Takashi Kido; Hiroshi Ishimoto; Hiroshi Ishii; Kanako Hara; Mutsumi Ozasa; Hiroki Kawabata; Toshinori Kawanami; Yu Suzuki; Hiroki Yoshikawa; Atsuko Hara; Noriho Sakamoto; Nobuhiro Matsumoto; Chiharu Yoshii; Junya Fukuoka; Masaki Fujita; Masamitsu Nakazato; Junichi Kadota; Hiroshi Mukae; Kazuhiro Yatera
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.